Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,172 public trials 550 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1

NCT02170727

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Local Institution Kazan', Russia

Local Institution Moscow, Russia

Local Institution Busan, South Korea

Local Institution Busan, South Korea

View all 20 locations

View Trial Details

Completed

A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir

NCT03234036

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

NCT01441063

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Castleman Disease, +29 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Prevalence of HBV in Pregnant Women Attending Antenatal Care in Tanzania

NCT04325542

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Bugando Medical Center Mwanza, Tanzania

View Trial Details

Completed

B/F/TAF Ease of Swallowability Trial

NCT04600687

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: John McKinnon Detroit, Michigan, United States

View Trial Details

Completed

Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs

NCT02609893

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Substance Use Research Unit San Francisco, California, United States

View Trial Details

Completed

Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

NCT03020095

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

A Multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" Intervention to Improve Maternal and Child Outcomes in Lesotho

NCT04598958

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)

NCT03368053

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

HCV Epidemiological Survey in China Rural Area

NCT04593355

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: First Hospital Jilin University Changchun, Jilin, China

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions